BioMed X Institute and Boehringer Ingelheim Successfully Complete Schizophrenia Research Project
The research of BioMed X team EPD - Early Intervention in Psychiatric Diseases - has shed light on the molecular mechanisms underlying white matter deficits in schizophrenia. HEIDELBERG, GERMANY / ACCESSWIRE / May 28, 2024 / German independent …